European private equity firm EMZ Partners has acquired a majority stake in FotoFinder, the leading provider of visualisation technology for early skin cancer detection and aesthetics, headquartered in Bad Birnbach, Germany.
FotoFinder, founded in 1991, provides products and services to dermatologists, dermatology clinics, hospitals, screening centres and research institutes. The systems sold combine proprietary AI-based software with industry-leading Automatic Total Body Mapping (ATBM) and video dermoscopy technology to form integrated skin visualisation solutions.
EMZ Partners is a leading European investment company that sees itself as a partner to medium-sized companies. Its activities focus on investments alongside founders, family shareholders and managers. EMZ is majority controlled by its own employees and invests the money of institutional investors from Europe. From the current fund with a volume of over one billion euros, EMZ makes investments of between 10 and 150 million euros.
taxess provided tax and structural advice on the acquisition.